Dugel Pravin

President, DirectorIVERIC bio, Inc. (ISEE) · full profile →Form 4 · filed Jul 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Disposed to issuer(D)203K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2023Disposed to issuer(D)140K0
Jul 11, 2023Disposed to issuer(D)100K0
Jul 11, 2023Disposed to issuer(D)9K0
Jul 11, 2023Disposed to issuer(D)110K0
Jul 11, 2023Disposed to issuer(D)35K0
Jul 11, 2023Disposed to issuer(D)50K0
Jul 11, 2023Disposed to issuer(D)38K0
Jul 11, 2023Disposed to issuer(D)70K0
Jul 11, 2023Disposed to issuer(D)28K0
Jul 11, 2023Disposed to issuer(D)300K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-080684) within minutes of acceptance. Every field above traces to the original document. Verify it directly: